APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immunoprecipitation (IP) Kit

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Immunoprecipitation (IP) Kit Industry Growth and Trends Forecast to 2032

22 December 2025113 pages

Choose your research edition.

Industry ResearchImmunoprecipitation (IP) Kit Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Immunoprecipitation (IP) Kit Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Immunoprecipitation (IP) Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immunoprecipitation (IP) Kit Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Immunoprecipitation (IP) Kit Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Immunoprecipitation (IP) Kit market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Immunoprecipitation (IP) Kit is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Immunoprecipitation (IP) Kit is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immunoprecipitation (IP) Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Immunoprecipitation (IP) Kit include Abbkine Scientific Co., Ltd., Active Motif, CD Bioparticles, Cell Signaling Technology, Inc., Engibody Biotechnology, Inc., MyBiosource, Inc., Novus Biologicals, Proteintech Group, Inc. and Rockland Immunochemicals, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Immunoprecipitation (IP) Kit market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Immunoprecipitation (IP) Kit market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Immunoprecipitation (IP) Kit market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Immunoprecipitation (IP) Kit.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Immunoprecipitation (IP) Kit market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Immunoprecipitation (IP) Kit Market by Company

Abbkine Scientific Co., Ltd.

Active Motif

CD Bioparticles

Cell Signaling Technology, Inc.

Engibody Biotechnology, Inc.

MyBiosource, Inc.

Novus Biologicals

Proteintech Group, Inc.

Rockland Immunochemicals, Inc.

Sino Biological, Inc.

Takara Bio Inc.

Merck KGaA

ACE Biotechnology

Thermo Fisher Scientific (China) Co., Ltd.

Beyotime Biotech. Inc.

Shanghai Epizyme Biomedical Technology Co., Ltd

Beaver

Wuhan Dia-An Biotechnology Co., Ltd

Immunoprecipitation (IP) Kit Segment by Type

Protein A

Protein G

Immunoprecipitation (IP) Kit Segment by Application

Pharmaceuticals and Biotechnology

Hospital and Diagnostic Laboratory

Research Institute

Other

Immunoprecipitation (IP) Kit Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunoprecipitation (IP) Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunoprecipitation (IP) Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunoprecipitation (IP) Kit.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Immunoprecipitation (IP) Kit manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Immunoprecipitation (IP) Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Protein A Table 2. Major Company of Protein G Table 3. Global Immunoprecipitation (IP) Kit Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Immunoprecipitation (IP) Kit Sales by Type (2021-2026) & (k units) Table 5. Global Immunoprecipitation (IP) Kit Sales Market Share in Volume by Type (2021-2026) Table 6. Global Immunoprecipitation (IP) Kit Sales by Type (2021-2026) & (US$ Million) Table 7. Global Immunoprecipitation (IP) Kit Sales Market Share in Value by Type (2021-2026) Table 8. Global Immunoprecipitation (IP) Kit Price by Type (2021-2026) & (US$/unit) Table 9. Global Immunoprecipitation (IP) Kit Sales by Type (2027-2032) & (k units) Table 10. Global Immunoprecipitation (IP) Kit Sales Market Share in Volume by Type (2027-2032) Table 11. Global Immunoprecipitation (IP) Kit Sales by Type (2027-2032) & (US$ Million) Table 12. Global Immunoprecipitation (IP) Kit Sales Market Share in Value by Type (2027-2032) Table 13. Global Immunoprecipitation (IP) Kit Price by Type (2027-2032) & (US$/unit) Table 14. North America Immunoprecipitation (IP) Kit Sales by Type (2021-2026) & (k units) Table 15. North America Immunoprecipitation (IP) Kit Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Immunoprecipitation (IP) Kit Sales by Type (2021-2026) & (k units) Table 17. Europe Immunoprecipitation (IP) Kit Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Immunoprecipitation (IP) Kit Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Immunoprecipitation (IP) Kit Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Immunoprecipitation (IP) Kit Sales by Type (2021-2026) & (k units) Table 21. Latin America Immunoprecipitation (IP) Kit Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Immunoprecipitation (IP) Kit Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Immunoprecipitation (IP) Kit Sales by Type (2021-2026) & (US$ Million) Table 24. Immunoprecipitation (IP) Kit Industry Trends Table 25. Immunoprecipitation (IP) Kit Industry Drivers Table 26. Immunoprecipitation (IP) Kit Industry Opportunities and Challenges Table 27. Immunoprecipitation (IP) Kit Industry Restraints Table 28. Global Immunoprecipitation (IP) Kit Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Immunoprecipitation (IP) Kit Revenue Market Share by Company (2021-2026) Table 30. Global Immunoprecipitation (IP) Kit Sales by Company (2021-2026) & (k units) Table 31. Global Immunoprecipitation (IP) Kit Sales Share by Company (2021-2026) Table 32. Global Immunoprecipitation (IP) Kit Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Immunoprecipitation (IP) Kit Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Immunoprecipitation (IP) Kit Major Company Production Sites and Headquarters Table 35. Global Immunoprecipitation (IP) Kit Company, Product Type & Application Table 36. Global Immunoprecipitation (IP) Kit Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Immunoprecipitation (IP) Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Immunoprecipitation (IP) Kit Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Immunoprecipitation (IP) Kit Sales by Region (2021-2026) & (k units) Table 41. Global Immunoprecipitation (IP) Kit Sales Market Share in Volume by Region (2021-2026) Table 42. Global Immunoprecipitation (IP) Kit Sales by Region (2021-2026) & (US$ Million) Table 43. Global Immunoprecipitation (IP) Kit Sales Market Share in Value by Region (2021-2026) Table 44. Global Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Immunoprecipitation (IP) Kit Sales by Region (2027-2032) & (k units) Table 46. Global Immunoprecipitation (IP) Kit Sales Market Share in Volume by Region (2027-2032) Table 47. Global Immunoprecipitation (IP) Kit Sales by Region (2027-2032) & (US$ Million) Table 48. Global Immunoprecipitation (IP) Kit Sales Market Share in Value by Region (2027-2032) Table 49. Global Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Immunoprecipitation (IP) Kit Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Immunoprecipitation (IP) Kit Sales by Application (2021-2026) & (k units) Table 52. Global Immunoprecipitation (IP) Kit Sales Market Share in Volume by Application (2021-2026) Table 53. Global Immunoprecipitation (IP) Kit Sales by Application (2021-2026) & (US$ Million) Table 54. Global Immunoprecipitation (IP) Kit Sales Market Share in Value by Application (2021-2026) Table 55. Global Immunoprecipitation (IP) Kit Price by Application (2021-2026) & (US$/unit) Table 56. Global Immunoprecipitation (IP) Kit Sales by Application (2027-2032) & (k units) Table 57. Global Immunoprecipitation (IP) Kit Sales Market Share in Volume by Application (2027-2032) Table 58. Global Immunoprecipitation (IP) Kit Sales by Application (2027-2032) & (US$ Million) Table 59. Global Immunoprecipitation (IP) Kit Sales Market Share in Value by Application (2027-2032) Table 60. Global Immunoprecipitation (IP) Kit Price by Application (2027-2032) & (US$/unit) Table 61. North America Immunoprecipitation (IP) Kit Sales by Application (2021-2026) & (k units) Table 62. North America Immunoprecipitation (IP) Kit Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Immunoprecipitation (IP) Kit Sales by Application (2021-2026) & (k units) Table 64. Europe Immunoprecipitation (IP) Kit Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Immunoprecipitation (IP) Kit Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Immunoprecipitation (IP) Kit Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Immunoprecipitation (IP) Kit Sales by Application (2021-2026) & (k units) Table 68. Latin America Immunoprecipitation (IP) Kit Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Immunoprecipitation (IP) Kit Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Immunoprecipitation (IP) Kit Sales by Application (2021-2026) & (US$ Million) Table 71. Abbkine Scientific Co., Ltd. Company Information Table 72. Abbkine Scientific Co., Ltd. Business Overview Table 73. Abbkine Scientific Co., Ltd. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Abbkine Scientific Co., Ltd. Immunoprecipitation (IP) Kit Product Portfolio Table 75. Abbkine Scientific Co., Ltd. Recent Development Table 76. Active Motif Company Information Table 77. Active Motif Business Overview Table 78. Active Motif Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Active Motif Immunoprecipitation (IP) Kit Product Portfolio Table 80. Active Motif Recent Development Table 81. CD Bioparticles Company Information Table 82. CD Bioparticles Business Overview Table 83. CD Bioparticles Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. CD Bioparticles Immunoprecipitation (IP) Kit Product Portfolio Table 85. CD Bioparticles Recent Development Table 86. Cell Signaling Technology, Inc. Company Information Table 87. Cell Signaling Technology, Inc. Business Overview Table 88. Cell Signaling Technology, Inc. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Cell Signaling Technology, Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 90. Cell Signaling Technology, Inc. Recent Development Table 91. Engibody Biotechnology, Inc. Company Information Table 92. Engibody Biotechnology, Inc. Business Overview Table 93. Engibody Biotechnology, Inc. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Engibody Biotechnology, Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 95. Engibody Biotechnology, Inc. Recent Development Table 96. MyBiosource, Inc. Company Information Table 97. MyBiosource, Inc. Business Overview Table 98. MyBiosource, Inc. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. MyBiosource, Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 100. MyBiosource, Inc. Recent Development Table 101. Novus Biologicals Company Information Table 102. Novus Biologicals Business Overview Table 103. Novus Biologicals Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Novus Biologicals Immunoprecipitation (IP) Kit Product Portfolio Table 105. Novus Biologicals Recent Development Table 106. Proteintech Group, Inc. Company Information Table 107. Proteintech Group, Inc. Business Overview Table 108. Proteintech Group, Inc. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Proteintech Group, Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 110. Proteintech Group, Inc. Recent Development Table 111. Rockland Immunochemicals, Inc. Company Information Table 112. Rockland Immunochemicals, Inc. Business Overview Table 113. Rockland Immunochemicals, Inc. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Rockland Immunochemicals, Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 115. Rockland Immunochemicals, Inc. Recent Development Table 116. Sino Biological, Inc. Company Information Table 117. Sino Biological, Inc. Business Overview Table 118. Sino Biological, Inc. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Sino Biological, Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 120. Sino Biological, Inc. Recent Development Table 121. Takara Bio Inc. Company Information Table 122. Takara Bio Inc. Business Overview Table 123. Takara Bio Inc. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Takara Bio Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 125. Takara Bio Inc. Recent Development Table 126. Merck KGaA Company Information Table 127. Merck KGaA Business Overview Table 128. Merck KGaA Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Merck KGaA Immunoprecipitation (IP) Kit Product Portfolio Table 130. Merck KGaA Recent Development Table 131. ACE Biotechnology Company Information Table 132. ACE Biotechnology Business Overview Table 133. ACE Biotechnology Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. ACE Biotechnology Immunoprecipitation (IP) Kit Product Portfolio Table 135. ACE Biotechnology Recent Development Table 136. Thermo Fisher Scientific (China) Co., Ltd. Company Information Table 137. Thermo Fisher Scientific (China) Co., Ltd. Business Overview Table 138. Thermo Fisher Scientific (China) Co., Ltd. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Thermo Fisher Scientific (China) Co., Ltd. Immunoprecipitation (IP) Kit Product Portfolio Table 140. Thermo Fisher Scientific (China) Co., Ltd. Recent Development Table 141. Beyotime Biotech. Inc. Company Information Table 142. Beyotime Biotech. Inc. Business Overview Table 143. Beyotime Biotech. Inc. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Beyotime Biotech. Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 145. Beyotime Biotech. Inc. Recent Development Table 146. Shanghai Epizyme Biomedical Technology Co., Ltd Company Information Table 147. Shanghai Epizyme Biomedical Technology Co., Ltd Business Overview Table 148. Shanghai Epizyme Biomedical Technology Co., Ltd Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. Shanghai Epizyme Biomedical Technology Co., Ltd Immunoprecipitation (IP) Kit Product Portfolio Table 150. Shanghai Epizyme Biomedical Technology Co., Ltd Recent Development Table 151. Beaver Company Information Table 152. Beaver Business Overview Table 153. Beaver Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 154. Beaver Immunoprecipitation (IP) Kit Product Portfolio Table 155. Beaver Recent Development Table 156. Wuhan Dia-An Biotechnology Co., Ltd Company Information Table 157. Wuhan Dia-An Biotechnology Co., Ltd Business Overview Table 158. Wuhan Dia-An Biotechnology Co., Ltd Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 159. Wuhan Dia-An Biotechnology Co., Ltd Immunoprecipitation (IP) Kit Product Portfolio Table 160. Wuhan Dia-An Biotechnology Co., Ltd Recent Development Table 161. North America Immunoprecipitation (IP) Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. North America Immunoprecipitation (IP) Kit Sales by Country (2021-2026) & (k units) Table 163. North America Immunoprecipitation (IP) Kit Sales Market Share by Country (2021-2026) Table 164. North America Immunoprecipitation (IP) Kit Sales Forecast by Country (2027-2032) & (k units) Table 165. North America Immunoprecipitation (IP) Kit Sales Market Share Forecast by Country (2027-2032) Table 166. North America Immunoprecipitation (IP) Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. North America Immunoprecipitation (IP) Kit Market Size by Country (2021-2026) & (US$ Million) Table 168. North America Immunoprecipitation (IP) Kit Market Share by Country (2021-2026) Table 169. North America Immunoprecipitation (IP) Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. North America Immunoprecipitation (IP) Kit Market Share Forecast by Country (2027-2032) Table 171. Europe Immunoprecipitation (IP) Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Europe Immunoprecipitation (IP) Kit Sales by Country (2021-2026) & (k units) Table 173. Europe Immunoprecipitation (IP) Kit Sales Market Share by Country (2021-2026) Table 174. Europe Immunoprecipitation (IP) Kit Sales Forecast by Country (2027-2032) & (k units) Table 175. Europe Immunoprecipitation (IP) Kit Sales Market Share Forecast by Country (2027-2032) Table 176. Europe Immunoprecipitation (IP) Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Europe Immunoprecipitation (IP) Kit Market Size by Country (2021-2026) & (US$ Million) Table 178. Europe Immunoprecipitation (IP) Kit Market Share by Country (2021-2026) Table 179. Europe Immunoprecipitation (IP) Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Europe Immunoprecipitation (IP) Kit Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Immunoprecipitation (IP) Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Immunoprecipitation (IP) Kit Sales by Country (2021-2026) & (k units) Table 183. Asia-Pacific Immunoprecipitation (IP) Kit Sales Market Share by Country (2021-2026) Table 184. Asia-Pacific Immunoprecipitation (IP) Kit Sales Forecast by Country (2027-2032) & (k units) Table 185. Asia-Pacific Immunoprecipitation (IP) Kit Sales Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific Immunoprecipitation (IP) Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific Immunoprecipitation (IP) Kit Market Size by Country (2021-2026) & (US$ Million) Table 188. Asia-Pacific Immunoprecipitation (IP) Kit Market Share by Country (2021-2026) Table 189. Asia-Pacific Immunoprecipitation (IP) Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Asia-Pacific Immunoprecipitation (IP) Kit Market Share Forecast by Country (2027-2032) Table 191. Latin America Immunoprecipitation (IP) Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 192. Latin America Immunoprecipitation (IP) Kit Sales by Country (2021-2026) & (k units) Table 193. Latin America Immunoprecipitation (IP) Kit Sales Market Share by Country (2021-2026) Table 194. Latin America Immunoprecipitation (IP) Kit Sales Forecast by Country (2027-2032) & (k units) Table 195. Latin America Immunoprecipitation (IP) Kit Sales Market Share Forecast by Country (2027-2032) Table 196. Latin America Immunoprecipitation (IP) Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Latin America Immunoprecipitation (IP) Kit Market Size by Country (2021-2026) & (US$ Million) Table 198. Latin America Immunoprecipitation (IP) Kit Market Share by Country (2021-2026) Table 199. Latin America Immunoprecipitation (IP) Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Latin America Immunoprecipitation (IP) Kit Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Immunoprecipitation (IP) Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Immunoprecipitation (IP) Kit Sales by Country (2021-2026) & (k units) Table 203. Middle East and Africa Immunoprecipitation (IP) Kit Sales Market Share by Country (2021-2026) Table 204. Middle East and Africa Immunoprecipitation (IP) Kit Sales Forecast by Country (2027-2032) & (k units) Table 205. Middle East and Africa Immunoprecipitation (IP) Kit Sales Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa Immunoprecipitation (IP) Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa Immunoprecipitation (IP) Kit Market Size by Country (2021-2026) & (US$ Million) Table 208. Middle East and Africa Immunoprecipitation (IP) Kit Market Share by Country (2021-2026) Table 209. Middle East and Africa Immunoprecipitation (IP) Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Middle East and Africa Immunoprecipitation (IP) Kit Market Share Forecast by Country (2027-2032) Table 211. Key Raw Materials Table 212. Raw Materials Key Suppliers Table 213. Immunoprecipitation (IP) Kit Distributors List Table 214. Immunoprecipitation (IP) Kit Customers List Table 215. Research Programs/Design for This Report Table 216. Authors List of This Report Table 217. Secondary Sources Table 218. Primary Sources List of Figures Figure 1. Immunoprecipitation (IP) Kit Image Figure 2. Global Immunoprecipitation (IP) Kit Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immunoprecipitation (IP) Kit Market Size (2021-2032) & (US$ Million) Figure 4. Global Immunoprecipitation (IP) Kit Sales (2021-2032) & (k units) Figure 5. Protein A Image Figure 6. Global Protein A Sales YoY Growth (2021-2032) & (k units) Figure 7. Protein G Image Figure 8. Global Protein G Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Immunoprecipitation (IP) Kit Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Immunoprecipitation (IP) Kit Market Share by Type 2025 VS 2032 Figure 11. North America Immunoprecipitation (IP) Kit Sales Market Share in Volume by Type in 2025 Figure 12. North America Immunoprecipitation (IP) Kit Sales Market Share in Value by Type in 2025 Figure 13. Europe Immunoprecipitation (IP) Kit Sales Market Share in Volume by Type in 2025 Figure 14. Europe Immunoprecipitation (IP) Kit Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Immunoprecipitation (IP) Kit Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Immunoprecipitation (IP) Kit Sales Market Share in Value by Type in 2025 Figure 17. Latin America Immunoprecipitation (IP) Kit Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Immunoprecipitation (IP) Kit Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Immunoprecipitation (IP) Kit Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Immunoprecipitation (IP) Kit Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Immunoprecipitation (IP) Kit Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Pharmaceuticals and Biotechnology Image Figure 24. Global Pharmaceuticals and Biotechnology Sales YoY Growth (2021-2032) & (k units) Figure 25. Hospital and Diagnostic Laboratory Image Figure 26. Global Hospital and Diagnostic Laboratory Sales YoY Growth (2021-2032) & (k units) Figure 27. Research Institute Image Figure 28. Global Research Institute Sales YoY Growth (2021-2032) & (k units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Immunoprecipitation (IP) Kit Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Immunoprecipitation (IP) Kit Market Share by Application 2025 VS 2032 Figure 33. North America Immunoprecipitation (IP) Kit Sales Market Share in Volume by Application in 2025 Figure 34. North America Immunoprecipitation (IP) Kit Sales Market Share in Value by Application in 2025 Figure 35. Europe Immunoprecipitation (IP) Kit Sales Market Share in Volume by Application in 2025 Figure 36. Europe Immunoprecipitation (IP) Kit Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Immunoprecipitation (IP) Kit Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Immunoprecipitation (IP) Kit Sales Market Share in Value by Application in 2025 Figure 39. Latin America Immunoprecipitation (IP) Kit Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Immunoprecipitation (IP) Kit Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Immunoprecipitation (IP) Kit Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Immunoprecipitation (IP) Kit Sales Market Share in Value by Application in 2025 Figure 43. North America Immunoprecipitation (IP) Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Immunoprecipitation (IP) Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Immunoprecipitation (IP) Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Immunoprecipitation (IP) Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Immunoprecipitation (IP) Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Immunoprecipitation (IP) Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Immunoprecipitation (IP) Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Immunoprecipitation (IP) Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Immunoprecipitation (IP) Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Immunoprecipitation (IP) Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Immunoprecipitation (IP) Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Immunoprecipitation (IP) Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Immunoprecipitation (IP) Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Immunoprecipitation (IP) Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Immunoprecipitation (IP) Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Immunoprecipitation (IP) Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Immunoprecipitation (IP) Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Immunoprecipitation (IP) Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Immunoprecipitation (IP) Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Immunoprecipitation (IP) Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Immunoprecipitation (IP) Kit Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Immunoprecipitation (IP) Kit Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Protein A
  • Protein G
Applications
  • Pharmaceuticals and Biotechnology
  • Hospital and Diagnostic Laboratory
  • Research Institute
  • Other
Companies covered
  • Abbkine Scientific Co., Ltd.
  • Active Motif
  • CD Bioparticles
  • Cell Signaling Technology, Inc.
  • Engibody Biotechnology, Inc.
  • MyBiosource, Inc.
  • Novus Biologicals
  • Proteintech Group, Inc.
  • Rockland Immunochemicals, Inc.
  • Sino Biological, Inc.
  • Takara Bio Inc.
  • Merck KGaA
  • ACE Biotechnology
  • Thermo Fisher Scientific (China) Co., Ltd.
  • Beyotime Biotech. Inc.
  • Shanghai Epizyme Biomedical Technology Co., Ltd
  • Beaver
  • Wuhan Dia-An Biotechnology Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Immunoprecipitation (IP) Kit Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Immunoprecipitation (IP) Kit Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Immunoprecipitation (IP) Kit Market by Type
  6. 1.3.1 Protein A
  7. 1.3.2 Protein G
  8. 1.4 Global Immunoprecipitation (IP) Kit Market Size by Type
  9. 1.4.1 Global Immunoprecipitation (IP) Kit Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Immunoprecipitation (IP) Kit Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Immunoprecipitation (IP) Kit Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Immunoprecipitation (IP) Kit Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Immunoprecipitation (IP) Kit Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Immunoprecipitation (IP) Kit Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Immunoprecipitation (IP) Kit Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Immunoprecipitation (IP) Kit Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Immunoprecipitation (IP) Kit Industry Trends
  2. 2.2 Immunoprecipitation (IP) Kit Industry Drivers
  3. 2.3 Immunoprecipitation (IP) Kit Industry Opportunities and Challenges
  4. 2.4 Immunoprecipitation (IP) Kit Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Immunoprecipitation (IP) Kit Revenue (2021-2026)
  2. 3.2 Global Top Players by Immunoprecipitation (IP) Kit Sales (2021-2026)
  3. 3.3 Global Top Players by Immunoprecipitation (IP) Kit Price (2021-2026)
  4. 3.4 Global Immunoprecipitation (IP) Kit Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Immunoprecipitation (IP) Kit Major Company Production Sites & Headquarters
  6. 3.6 Global Immunoprecipitation (IP) Kit Company, Product Type & Application
  7. 3.7 Global Immunoprecipitation (IP) Kit Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Immunoprecipitation (IP) Kit Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Immunoprecipitation (IP) Kit Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Immunoprecipitation (IP) Kit Tier 1, Tier 2, and Tier 3
4 Immunoprecipitation (IP) Kit Regional Status and Outlook
  1. 4.1 Global Immunoprecipitation (IP) Kit Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Immunoprecipitation (IP) Kit Historic Market Size by Region
  3. 4.2.1 Global Immunoprecipitation (IP) Kit Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Immunoprecipitation (IP) Kit Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Immunoprecipitation (IP) Kit Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Immunoprecipitation (IP) Kit Forecasted Market Size by Region
  7. 4.3.1 Global Immunoprecipitation (IP) Kit Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Immunoprecipitation (IP) Kit Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Immunoprecipitation (IP) Kit Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Immunoprecipitation (IP) Kit by Application
  1. 5.1 Immunoprecipitation (IP) Kit Market by Application
  2. 5.1.1 Pharmaceuticals and Biotechnology
  3. 5.1.2 Hospital and Diagnostic Laboratory
  4. 5.1.3 Research Institute
  5. 5.1.4 Other
  6. 5.2 Global Immunoprecipitation (IP) Kit Market Size by Application
  7. 5.2.1 Global Immunoprecipitation (IP) Kit Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Immunoprecipitation (IP) Kit Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Immunoprecipitation (IP) Kit Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Immunoprecipitation (IP) Kit Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Immunoprecipitation (IP) Kit Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Immunoprecipitation (IP) Kit Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Immunoprecipitation (IP) Kit Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Immunoprecipitation (IP) Kit Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbkine Scientific Co., Ltd.
  2. 6.1.1 Abbkine Scientific Co., Ltd. Company Information
  3. 6.1.2 Abbkine Scientific Co., Ltd. Business Overview
  4. 6.1.3 Abbkine Scientific Co., Ltd. Immunoprecipitation (IP) Kit Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbkine Scientific Co., Ltd. Immunoprecipitation (IP) Kit Product Portfolio
  6. 6.1.5 Abbkine Scientific Co., Ltd. Recent Developments
  7. 6.2 Active Motif
  8. 6.2.1 Active Motif Company Information
  9. 6.2.2 Active Motif Business Overview
  10. 6.2.3 Active Motif Immunoprecipitation (IP) Kit Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Active Motif Immunoprecipitation (IP) Kit Product Portfolio
  12. 6.2.5 Active Motif Recent Developments
  13. 6.3 CD Bioparticles
  14. 6.3.1 CD Bioparticles Company Information
  15. 6.3.2 CD Bioparticles Business Overview
  16. 6.3.3 CD Bioparticles Immunoprecipitation (IP) Kit Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CD Bioparticles Immunoprecipitation (IP) Kit Product Portfolio
  18. 6.3.5 CD Bioparticles Recent Developments
  19. 6.4 Cell Signaling Technology, Inc.
  20. 6.4.1 Cell Signaling Technology, Inc. Company Information
  21. 6.4.2 Cell Signaling Technology, Inc. Business Overview
  22. 6.4.3 Cell Signaling Technology, Inc. Immunoprecipitation (IP) Kit Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Cell Signaling Technology, Inc. Immunoprecipitation (IP) Kit Product Portfolio
  24. 6.4.5 Cell Signaling Technology, Inc. Recent Developments
  25. 6.5 Engibody Biotechnology, Inc.
  26. 6.5.1 Engibody Biotechnology, Inc. Company Information
  27. 6.5.2 Engibody Biotechnology, Inc. Business Overview
  28. 6.5.3 Engibody Biotechnology, Inc. Immunoprecipitation (IP) Kit Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Engibody Biotechnology, Inc. Immunoprecipitation (IP) Kit Product Portfolio
  30. 6.5.5 Engibody Biotechnology, Inc. Recent Developments
  31. 6.6 MyBiosource, Inc.
  32. 6.6.1 MyBiosource, Inc. Company Information
  33. 6.6.2 MyBiosource, Inc. Business Overview
  34. 6.6.3 MyBiosource, Inc. Immunoprecipitation (IP) Kit Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 MyBiosource, Inc. Immunoprecipitation (IP) Kit Product Portfolio
  36. 6.6.5 MyBiosource, Inc. Recent Developments
  37. 6.7 Novus Biologicals
  38. 6.7.1 Novus Biologicals Company Information
  39. 6.7.2 Novus Biologicals Business Overview
  40. 6.7.3 Novus Biologicals Immunoprecipitation (IP) Kit Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Novus Biologicals Immunoprecipitation (IP) Kit Product Portfolio
  42. 6.7.5 Novus Biologicals Recent Developments
  43. 6.8 Proteintech Group, Inc.
  44. 6.8.1 Proteintech Group, Inc. Company Information
  45. 6.8.2 Proteintech Group, Inc. Business Overview
  46. 6.8.3 Proteintech Group, Inc. Immunoprecipitation (IP) Kit Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Proteintech Group, Inc. Immunoprecipitation (IP) Kit Product Portfolio
  48. 6.8.5 Proteintech Group, Inc. Recent Developments
  49. 6.9 Rockland Immunochemicals, Inc.
  50. 6.9.1 Rockland Immunochemicals, Inc. Company Information
  51. 6.9.2 Rockland Immunochemicals, Inc. Business Overview
  52. 6.9.3 Rockland Immunochemicals, Inc. Immunoprecipitation (IP) Kit Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Rockland Immunochemicals, Inc. Immunoprecipitation (IP) Kit Product Portfolio
  54. 6.9.5 Rockland Immunochemicals, Inc. Recent Developments
  55. 6.10 Sino Biological, Inc.
  56. 6.10.1 Sino Biological, Inc. Company Information
  57. 6.10.2 Sino Biological, Inc. Business Overview
  58. 6.10.3 Sino Biological, Inc. Immunoprecipitation (IP) Kit Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sino Biological, Inc. Immunoprecipitation (IP) Kit Product Portfolio
  60. 6.10.5 Sino Biological, Inc. Recent Developments
  61. 6.11 Takara Bio Inc.
  62. 6.11.1 Takara Bio Inc. Company Information
  63. 6.11.2 Takara Bio Inc. Business Overview
  64. 6.11.3 Takara Bio Inc. Immunoprecipitation (IP) Kit Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Takara Bio Inc. Immunoprecipitation (IP) Kit Product Portfolio
  66. 6.11.5 Takara Bio Inc. Recent Developments
  67. 6.12 Merck KGaA
  68. 6.12.1 Merck KGaA Company Information
  69. 6.12.2 Merck KGaA Business Overview
  70. 6.12.3 Merck KGaA Immunoprecipitation (IP) Kit Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Merck KGaA Immunoprecipitation (IP) Kit Product Portfolio
  72. 6.12.5 Merck KGaA Recent Developments
  73. 6.13 ACE Biotechnology
  74. 6.13.1 ACE Biotechnology Company Information
  75. 6.13.2 ACE Biotechnology Business Overview
  76. 6.13.3 ACE Biotechnology Immunoprecipitation (IP) Kit Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 ACE Biotechnology Immunoprecipitation (IP) Kit Product Portfolio
  78. 6.13.5 ACE Biotechnology Recent Developments
  79. 6.14 Thermo Fisher Scientific (China) Co., Ltd.
  80. 6.14.1 Thermo Fisher Scientific (China) Co., Ltd. Company Information
  81. 6.14.2 Thermo Fisher Scientific (China) Co., Ltd. Business Overview
  82. 6.14.3 Thermo Fisher Scientific (China) Co., Ltd. Immunoprecipitation (IP) Kit Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Thermo Fisher Scientific (China) Co., Ltd. Immunoprecipitation (IP) Kit Product Portfolio
  84. 6.14.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments
  85. 6.15 Beyotime Biotech. Inc.
  86. 6.15.1 Beyotime Biotech. Inc. Company Information
  87. 6.15.2 Beyotime Biotech. Inc. Business Overview
  88. 6.15.3 Beyotime Biotech. Inc. Immunoprecipitation (IP) Kit Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Beyotime Biotech. Inc. Immunoprecipitation (IP) Kit Product Portfolio
  90. 6.15.5 Beyotime Biotech. Inc. Recent Developments
  91. 6.16 Shanghai Epizyme Biomedical Technology Co., Ltd
  92. 6.16.1 Shanghai Epizyme Biomedical Technology Co., Ltd Company Information
  93. 6.16.2 Shanghai Epizyme Biomedical Technology Co., Ltd Business Overview
  94. 6.16.3 Shanghai Epizyme Biomedical Technology Co., Ltd Immunoprecipitation (IP) Kit Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Shanghai Epizyme Biomedical Technology Co., Ltd Immunoprecipitation (IP) Kit Product Portfolio
  96. 6.16.5 Shanghai Epizyme Biomedical Technology Co., Ltd Recent Developments
  97. 6.17 Beaver
  98. 6.17.1 Beaver Company Information
  99. 6.17.2 Beaver Business Overview
  100. 6.17.3 Beaver Immunoprecipitation (IP) Kit Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Beaver Immunoprecipitation (IP) Kit Product Portfolio
  102. 6.17.5 Beaver Recent Developments
  103. 6.18 Wuhan Dia-An Biotechnology Co., Ltd
  104. 6.18.1 Wuhan Dia-An Biotechnology Co., Ltd Company Information
  105. 6.18.2 Wuhan Dia-An Biotechnology Co., Ltd Business Overview
  106. 6.18.3 Wuhan Dia-An Biotechnology Co., Ltd Immunoprecipitation (IP) Kit Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Wuhan Dia-An Biotechnology Co., Ltd Immunoprecipitation (IP) Kit Product Portfolio
  108. 6.18.5 Wuhan Dia-An Biotechnology Co., Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Immunoprecipitation (IP) Kit Sales by Country
  2. 7.1.1 North America Immunoprecipitation (IP) Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Immunoprecipitation (IP) Kit Sales by Country (2021-2026)
  4. 7.1.3 North America Immunoprecipitation (IP) Kit Sales Forecast by Country (2027-2032)
  5. 7.2 North America Immunoprecipitation (IP) Kit Market Size by Country
  6. 7.2.1 North America Immunoprecipitation (IP) Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Immunoprecipitation (IP) Kit Market Size by Country (2021-2026)
  8. 7.2.3 North America Immunoprecipitation (IP) Kit Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Immunoprecipitation (IP) Kit Sales by Country
  2. 8.1.1 Europe Immunoprecipitation (IP) Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Immunoprecipitation (IP) Kit Sales by Country (2021-2026)
  4. 8.1.3 Europe Immunoprecipitation (IP) Kit Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Immunoprecipitation (IP) Kit Market Size by Country
  6. 8.2.1 Europe Immunoprecipitation (IP) Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Immunoprecipitation (IP) Kit Market Size by Country (2021-2026)
  8. 8.2.3 Europe Immunoprecipitation (IP) Kit Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Immunoprecipitation (IP) Kit Sales by Country
  2. 9.1.1 Asia-Pacific Immunoprecipitation (IP) Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Immunoprecipitation (IP) Kit Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Immunoprecipitation (IP) Kit Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Immunoprecipitation (IP) Kit Market Size by Country
  6. 9.2.1 Asia-Pacific Immunoprecipitation (IP) Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Immunoprecipitation (IP) Kit Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Immunoprecipitation (IP) Kit Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Immunoprecipitation (IP) Kit Sales by Country
  2. 10.1.1 South America Immunoprecipitation (IP) Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Immunoprecipitation (IP) Kit Sales by Country (2021-2026)
  4. 10.1.3 South America Immunoprecipitation (IP) Kit Sales Forecast by Country (2027-2032)
  5. 10.2 South America Immunoprecipitation (IP) Kit Market Size by Country
  6. 10.2.1 South America Immunoprecipitation (IP) Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Immunoprecipitation (IP) Kit Market Size by Country (2021-2026)
  8. 10.2.3 South America Immunoprecipitation (IP) Kit Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Immunoprecipitation (IP) Kit Sales by Country
  2. 11.1.1 Middle East and Africa Immunoprecipitation (IP) Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Immunoprecipitation (IP) Kit Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Immunoprecipitation (IP) Kit Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Immunoprecipitation (IP) Kit Market Size by Country
  6. 11.2.1 Middle East and Africa Immunoprecipitation (IP) Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Immunoprecipitation (IP) Kit Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Immunoprecipitation (IP) Kit Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Immunoprecipitation (IP) Kit Value Chain Analysis
  2. 12.1.1 Immunoprecipitation (IP) Kit Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Immunoprecipitation (IP) Kit Production Mode & Process
  7. 12.2 Immunoprecipitation (IP) Kit Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Immunoprecipitation (IP) Kit Distributors
  10. 12.2.3 Immunoprecipitation (IP) Kit Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst